Business
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Hi, what are you looking for?
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Allergan's David Pyott had to fight Bill Ackman Day and Night to avoid a takeover by Valeant.
The comparatively low level of cash assets currently held by hedge fund mogul Bill Ackman probably means that he won’t be making any activist...
Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the...
Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker...
– Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc.,...
The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical...
After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company,...
On CNBC’s Mad Dash segment, Jim Cramer discussed “one of my favorite stocks, ” Zoetis, an animal health drug company spun off by Pfizer....
– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and...